Personalized exercise trial for chronic fatigue ends early
NCT ID NCT05899595
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a personalized exercise program could reduce fatigue in people with chronic fatigue syndrome. About 101 participants were planned, but the trial was terminated early. The approach involved tailoring aerobic and resistance exercises based on weekly fatigue and muscle assessments. Because it stopped early, we cannot draw firm conclusions about its effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- personalized physical exercise program
- What this could lead to
- If it had succeeded, this could have pointed toward a tailored exercise approach to help reduce fatigue in people with chronic fatigue syndrome.
- What could go wrong
- The trial was terminated early, so we don't have clear results. It was also a small study, and exercise may not work for everyone with chronic fatigue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
101 people
The number who actually took part.
- Started
-
Sep 2023
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Aged ≥ 18 * Men or women * FACIT-F score ≤ 34 * Ability to walk during 10 minutes without stopping * Ability to receive the Myocene® stimulation protocol * Have given written consent * Members or beneficiaries of a social security program Exclusion Criteria: * Contraindication to experimental procedures * Important health issues that would compromise the participant security during the study * Persistent atrial fibrillation or 2nd or 3rd degree atrioventricular block * Currently participating in an other interventional study or having so in the past thirty days * Patient is pregnant * Patient is unable to give an informed consent * Patient is deprived of liberty or under guardianship
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fatigue syndrome, chronic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de Saint-Etienne
Saint-Etienne, 42055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient remedy meets modern prebiotic: a new hope for Shift-Worker fatigue?
- Could a laser beam ease the pain of Ehlers-Danlos syndrome?
- Testosterone shot may ease fatigue in young cancer survivors
- Light strokes, big relief? touch therapy eases cancer fatigue
- Can a simple exercise test tell ME/CFS apart from heart disease?
- Hidden toll: study reveals caregiver struggles after stroke